newsfilter
← Latest News
Business Wire·

Acorda Shareholders Invited to Virtual Q&A with CEO Ron Cohen, M.D.

October 28, 2022 at 1pm ET, 10am PT Shareholders are invited to submit questions to the CEO Acorda Therapeutics, Inc. (NASDAQ:ACOR) will hold a virtual, video Q&A with its CEO, Ron Cohen, M.D., on Friday, October